Latest Insider Transactions at Rapport Therapeutics, Inc. (RAPP)
This section provides a real-time view of insider transactions for Rapport Therapeutics, Inc. (RAPP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Rapport Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Rapport Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 01
2024
|
James Healy Director |
BUY
Open market or private purchase
|
Indirect |
44,032
+10.4%
|
$1,056,768
$24.59 P/Share
|
|
Jun 10
2024
|
Arch Venture Partners Xii, LLC |
BUY
Conversion of derivative security
|
Indirect |
3,728,738
+50.0%
|
-
|
|
Jun 10
2024
|
Third Rock Ventures V, L.P. |
BUY
Conversion of derivative security
|
Indirect |
969,218
+50.0%
|
-
|
|
Jun 10
2024
|
Third Rock Ventures V, L.P. |
BUY
Conversion of derivative security
|
Direct |
6,551,449
+47.87%
|
-
|
|
Jun 10
2024
|
James Healy Director |
BUY
Open market or private purchase
|
Indirect |
558,824
+44.03%
|
$9,500,008
$17.0 P/Share
|
|
Jun 10
2024
|
James Healy Director |
BUY
Conversion of derivative security
|
Indirect |
1,392,738
+50.0%
|
-
|